Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hsinyen Huang
Institutions:
Ragon Institute of MGH, MIT and Harvard,
Mass General Brigham,
Massachusetts Institute of Technology
Observed institutions:
Ragon Institute of MGH, MIT and Harvard,
Mass General Brigham,
Massachusetts Institute of Technology,
Columbia University
ORCID:
0009-0005-2903-8322
Observed ORCID:
0009-0005-2903-8322
OpenAlex ID:
A5108867023
Engineered bacteria launch and control an oncolytic virus
2025
·
Zakary S. Singer
, Jonathan Pabón
, et al.
·
Nature Biomedical Engineering
·
57
PDF
Effector-primed TCF1 + CD8 + T cells elicited by a networked epitope vaccine stratify protection against SHIV acquisition
2026
·
Matthew A. Getz
, Aljawharah Alrubayyi
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
NK-like and networked CD8 + T cell immunity mediates exceptional HIV control
2026
·
Aljawharah Alrubayyi
, Anna K. Traunbauer
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 6841 Single cell proteomics by MS defines infection-infection heterogeneity
2026
·
James Kostas
, Hsinyen Huang
, et al.
·
Journal of Biological Chemistry
Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes
2025
·
Aljawharah Alrubayyi
, Hsinyen Huang
, et al.
·
Infectious Disease Clinics of North America
Abstract 6906: Engineered bacteria launch and control an oncolytic virus
2024
·
Jonathan Pabon
, Zakary Singer
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
57
H-index:
1
I10-index:
1
Year
Topic
Type